A case of refractory immune checkpoint inhibitor-induced colitis successfully treated with mirikizumab.

Remicade (infliximab) - J&J

Omvoh (mirikizumab-mrkz) - Eli Lilly

Entyvio (vedolizumab) - Takeda

Keytruda (pembrolizumab) - Merck (MSD)

http://www.ncbi.nlm.nih.gov/pubmed/42734774

Atsushi Yoshida; Hiroko Tsunoda; Junko Takei; Katsuyuki Fukuda; Koichi Takagi; Naoki Kanomata; Shino Babaguchi; Yuntae Kim

Sep 15, 2026